Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases
利用骨扫描和循环肿瘤细胞(CTC)进行骨扫描指数(BSI)评分:预测恩扎卢胺治疗去势抵抗性前列腺癌骨转移患者疗效的因素
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-35790-5
Hirano, Hisashi; Nagata, Masayoshi; Nagaya, Naoya; Nakamura, So; Ashizawa, Takeshi; Lu, Yan; Kawano, Haruna; Kitamura, Kosuke; Sakamoto, Yoshiro; Fujita, Kazuhiko; Isobe, Hideyuki; Tsujimura, Akira; Muto, Satoru; Horie, Shigeo